Higashimurayama, Japan

Takashi Maejima

This inventor holds 1 USPTO granted patent. Top assignees: Kowa Company Limited, Nissan Chemical Industries Limited. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Maejima. Retrieved from https://idiyas.com/inventor/takashi-maejima-hg2l4cq4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Maejima: Innovator in Hyperlipidemia Treatment

Introduction

Takashi Maejima is a notable inventor based in Higashimurayama, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of hyperlipidemia. His innovative approach has led to the development of a unique method that combines specific medications to effectively manage cholesterol levels.

Latest Patents

Takashi Maejima holds a patent for a method for treating hyperlipidemia. This patent outlines a process that involves administering effective doses of ezetimibe and pitavastatin or a salt or lactone derivative thereof. This innovative method aims to provide a more effective treatment option for individuals suffering from hyperlipidemia or hypercholesterolemia.

Career Highlights

Throughout his career, Takashi Maejima has worked with prominent companies such as Kowa Company Limited and Nissan Chemical Industries Limited. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical treatments.

Collaborations

Takashi has collaborated with notable professionals in his field, including Taro Aoki and Hiroyuki Yamazaki. These collaborations have fostered a productive environment for innovation and have led to significant advancements in medical treatments.

Conclusion

In summary, Takashi Maejima is a distinguished inventor whose work in treating hyperlipidemia has made a meaningful impact in the medical field. His innovative methods and collaborations with industry leaders highlight his commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…